Two El Paso hospital CEOs have been indicted in a large-scale healthcare fraud case, with accusations of their involvement in an elaborate pass-through billing scheme. Court documents reveal Jose Huerta, 58, and Israel Navarro, 47, allegedly conspired to submit false claims for urine drug tests (UDTs), defrauding Blue Cross Blue Shield of more than $12 million. The indictment, which details their supposed crimes, was filed on June 25 and includes charges of conspiracy to commit wire and mail fraud.
The indictment, obtained by the U.S. Department of Justice, accuses the duo of falsely claiming that patients had undergone UDTs within their facilities when they had not. The alleged scheme involved sending over $16 million in claims to a lab in the Dallas area for processing. Huerta and Navarro managed to turn themselves in last week to the FBI in El Paso and have been released on bond after making their initial appearances in court.
Should they be found guilty, Huerta and Navarro face sentences of up to 20 years for each count against them, as well as a financial hit—fines up to $250,000 for each charge. U.S. Attorney Justin R. Simmons for the Western District of Texas stressed that an indictment is "merely an allegation" and emphasized that the defendants are entitled to a presumption of innocence until proven guilty.
The case is now in the hands of Assistant U.S. Attorney Debra Kanof, with investigations jointly carried out by the FBI and the Texas Department of Insurance. The accused have not yet had the opportunity to fully respond to the allegations following their indictment. In a system committed to justice, the burden remains on the prosecution to not just accuse but to convincingly prove the guilt of Huerta and Navarro beyond a reasonable doubt.
